Literature DB >> 15337340

Hepatocyte growth factor (HGF) in patients with hepatitis B and meningitis.

M Ozden1, A Kalkan, K Demirdag, A Denk, S Sirri Kilic.   

Abstract

OBJECTIVES: The present study investigates serum hepatocyte growth factor (HGF) levels in patients with acute and chronic hepatitis B and the relation between these levels and intrahepatic inflammatory markers of the liver and fibrosis, as well as the cerebrospinal fluid (CSF) HGF levels in patients with meningitis and the relation between these levels and CSF findings. To our knowledge this is the first study regarding CSF HGF levels in tuberculous meningitis. PATIENTS AND METHODS: The study consisted of 35 patients with chronic hepatitis B (HbeAg and HBV-DNA positive), 20 with acute hepatitis B, 20 with acute bacterial meningitis and 15 having tuberculous meningitis. HGF levels in the serum and CSF samples were measured by using the ELISA method.
RESULTS: The mean serum HGF levels in acute hepatitis B group were found statistically significantly higher than those in the control group and chronic hepatitis B group (p<0.0001). It was established that serum HGF levels in patients with chronic hepatitis B were significantly correlated with serum alanine aminotransferase (ALT) and HBV-DNA levels (r: 0.816, 0.951; p<0.05, respectively). Similarly, serum HGF levels of patients with chronic hepatitis B were correlated with fibrosis score and hepatic activity index of the liver histopathology (r: 0.750, 0.459; p<0.05, respectively). The mean CSF HGF levels of patients with acute bacterial meningitis and tuberculous meningitis were higher than those in the control group (p<0.05). In addition, it was observed that mean CSF HGF levels in patients suffered from tuberculous meningitis were statistically significantly higher than those in acute bacterial meningitis (p<0.05).
CONCLUSIONS: We suggest that serum HGF level in patients with chronic hepatitis B might reflect viral load, necro-inflammatory activity in the liver and the degree of structural progression. Our findings have demonstrated that tuberculous meningitis cause increased HGF concentrations in CSF. It is, therefore, suggested that examination of HGF levels in CSF may provide additional information in the differential diagnosis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15337340     DOI: 10.1016/j.jinf.2003.12.001

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


  5 in total

1.  Association between Hepatocyte Growth Factor (HGF) Gene Polymorphisms and Serum HGF Levels in Patients with Rheumatoid Arthritis.

Authors:  Fatih Kara; Abdulkadir Yildirim; Musa Gumusdere; Saliha Karatay; Kadir Yildirim; Ebubekir Bakan
Journal:  Eurasian J Med       Date:  2014-08-26

2.  Fingerprint changes in CSF composition associated with different aetiologies in human neonatal hydrocephalus: inflammatory cytokines.

Authors:  Irum Naureen; Kh A Irfan Waheed; Ahsen W Rathore; Suresh Victor; Conor Mallucci; John R Goodden; Shahid N Chohan; Jaleel A Miyan
Journal:  Childs Nerv Syst       Date:  2014-04-15       Impact factor: 1.475

3.  Hepatocyte growth factor level in cerebrospinal fluid as an additional marker in patient with drug-resistant streptococcus pneumoniae meningitis treated with linezolid.

Authors:  Hung-Chin Tsai; Yao-Shen Chen; Susan Shin-Jung Lee; Yu-Hung Lin; Shue-Ren Wann; Cheng Len Sy; Yung-Ching Liu
Journal:  Clin Med Case Rep       Date:  2008-05-27

Review 4.  Dysregulation of Liver Regeneration by Hepatitis B Virus Infection: Impact on Development of Hepatocellular Carcinoma.

Authors:  Eun-Sook Park; Mehrangiz Dezhbord; Ah Ram Lee; Bo Bae Park; Kyun-Hwan Kim
Journal:  Cancers (Basel)       Date:  2022-07-22       Impact factor: 6.575

5.  Pulmonary and systemic hepatocyte and keratinocyte growth factors in patients with chronic obstructive pulmonary disease.

Authors:  Jaume Sauleda; Aina Noguera; David Blanquer; Jaume Pons; Meritxell López; Cristina Villena; Alvar G N Agustí
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2008
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.